Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation

BACKGROUND: Aprepitant, as a neurokinin-1 receptor (NK-1R) antagonist, originally applied for curing chemotherapy-induced nausea and vomiting, has been reported to have significant antitumor effect on several malignant tumors. However, the effect of aprepitant on gallbladder cancer (GBC) is not clea...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Xueyan, Yang, Yang, Zhou, Wei, Wang, Yue, Wang, Xue, Ge, Xianxiu, Wang, Fei, Zhou, Fangfang, Deng, Xueting, Miao, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204192/
https://www.ncbi.nlm.nih.gov/pubmed/37221457
http://dx.doi.org/10.1186/s12885-023-10954-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204192/
https://www.ncbi.nlm.nih.gov/pubmed/37221457
http://dx.doi.org/10.1186/s12885-023-10954-8

Ejemplares similares